Atrys Health (XMAD:ATRY) Days Sales Outstanding : 119.97 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Atrys Health Days Sales Outstanding?

Atrys Health's average Accounts Receivable for the six months ended in Dec. 2023 was €54.8 Mil. Atrys Health's Revenue for the six months ended in Dec. 2023 was €83.3 Mil. Hence, Atrys Health's Days Sales Outstanding for the six months ended in Dec. 2023 was 119.97.

The historical rank and industry rank for Atrys Health's Days Sales Outstanding or its related term are showing as below:

XMAD:ATRY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 90.81 Med: 147.28 Max: 217.83
Current: 99.6

During the past 8 years, Atrys Health's highest Days Sales Outstanding was 217.83. The lowest was 90.81. And the median was 147.28.

XMAD:ATRY's Days Sales Outstanding is ranked worse than
65.84% of 887 companies
in the Biotechnology industry
Industry Median: 72.43 vs XMAD:ATRY: 99.60

Atrys Health's Days Sales Outstanding declined from Dec. 2022 (142.12) to Dec. 2023 (119.97).

Atrys Health Days Sales Outstanding Historical Data

The historical data trend for Atrys Health's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atrys Health Days Sales Outstanding Chart

Atrys Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

147.55

147.01

105.90

125.22

90.81

Atrys Health Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial											124.99	108.71	142.12	92.74	119.97

Competitive Comparison of Atrys Health's Days Sales Outstanding

For the Biotechnology subindustry, Atrys Health's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Atrys Health's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atrys Health's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Atrys Health's Days Sales Outstanding falls into.

Atrys Health Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Atrys Health's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (55.457	+	44.847)	/	2 )	/	201.569	*	365
=	50.152					/	201.569	*	365
=	90.81

Atrys Health's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (64.712	+	44.847)	/	2 )	/	83.333	*	365 / 2
=	54.7795					/	83.333	*	365 / 2
=	119.97

Atrys Health (XMAD:ATRY) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Atrys Health Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Atrys Health's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Atrys Health (XMAD:ATRY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atrys Health SA (XMAD:ATRY) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

A2T:Germany

Address

c/ Provença, 392 planta baja, Barcelona, ESP, 08025

Website

http://www.atryshealth.com

Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.

Atrys Health (XMAD:ATRY) Headlines

No Headlines